home / stock / clzny / clzny news


CLZNY News and Press, Clariant AG ADR From 10/30/22

Stock Information

Company Name: Clariant AG ADR
Stock Symbol: CLZNY
Market: OTC

Menu

CLZNY CLZNY Quote CLZNY Short CLZNY News CLZNY Articles CLZNY Message Board
Get CLZNY Alerts

News, Short Squeeze, Breakout and More Instantly...

CLZNY - Clariant AG (CLZNF) Q3 2022 Earnings Call Transcript

Clariant AG (CLZNF) Q3 2022 Earnings Conference Call October 27, 2022 09:00 AM ET Company Participants Andreas Schwarzwaelder - Head, Investor Relations Conrad Keijzer - Chief Executive Officer Bill Collins - Chief Financial Officer Conference Call Particip...

CLZNY - Stepan Company: A Growing Dividend Stream Worth The Price

Stepan manufactures critical components for key industries. Recent headwinds, which are most likely temporary, have caused a decline of ~18% in the share price, but the PS ratio has suffered even more. The company is successfully increasing the base price of its products as it is ...

CLZNY - Clariant AG (CLZNF) CEO Conrad Keijzer on Q2 2022 Results - Earnings Call Transcript

Clariant AG (CLZNF) Q2 2022 Earnings Conference Call July 28, 2022 09:00 AM ET Company Participants Andreas Schwarzwaelder - Head, Investor Relations Conrad Keijzer - Chief Executive Officer Bill Collins - Chief Financial Officer Conference Call Participant...

CLZNY - Clariant AG 2022 Q2 - Results - Earnings Call Presentation

The following slide deck was published by Clariant AG in conjunction with their 2022 Q2 earnings call. For further details see: Clariant AG 2022 Q2 - Results - Earnings Call Presentation

CLZNY - Bragar Eagel & Squire, P.C. Is Investigating Carvana, Enochian, Corcept, and Clariant and Encourages Investors to Contact the Firm

NEW YORK, June 19, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Carvana Co. (NYSE: CVNA), Enochian Biosciences, Inc. (NASDAQ: ENOB), Corcept Therapeutics, Inc. (NASDAQ: CORT), and Cla...

CLZNY - Clariant AG (CLZNF) CEO Conrad Keijzer on Q1 2022 Results - Earnings Call Transcript

Clariant AG (CLZNF) Q1 2022 Earnings Conference Call June 15, 2022, 09:00 AM ET Company Participants Andreas Schwarzwaelder - Head of IR Conrad Keijzer - CEO Stephan Lynen - Executive VP & CFO Conference Call Participants Christian Faitz - Kepler Cheuvreux Andrew Stott - UBS Georgina Iwam...

CLZNY - Clariant AG 2022 Q1 - Results - Earnings Call Presentation

The following slide deck was published by Clariant AG in conjunction with their 2022 Q1 earnings call. For further details see: Clariant AG 2022 Q1 - Results - Earnings Call Presentation

CLZNY - Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Clariant AG To Contact Him Directly To Discuss Their Options

NEW YORK, NY / ACCESSWIRE / April 19, 2022 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Clariant AG ADR ("Clariant AG" or the "Company") (OTC PINK:CLZNY) . If you suffered losses exceeding $50,000 investing in Clariant AG st...

CLZNY - Clariant AG Shareholder Notice

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Clariant AG To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - February 24, 2022) - Faruqi & Faruqi, LLP, a leading national securities law f...

CLZNY - Clariant AG Update

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Clariant AG To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - February 18, 2022) - Faruqi & Faruqi, LLP, a leading national securities law f...

Previous 10 Next 10